Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ketamine for Acute Pain in ED
NCT03714620Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Oct 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in acute pain (2 arms), sponsored by Loyola University Chicago. Primary endpoint: Change in Pain Score From Baseline to 30 Minutes Post Initiation of Drug Administration. Started Oct 2018; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03714620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03714620.